Read the full judgment text of HCA 188/2018 on BabelCite. This High Court CFI judgment was delivered on 24 December 2020.
1. The subject matter in these proceedings is the beneficial ownership of 60% of the issued shares of Kai Cheung International Pharmaceutical Limited (啟璋(國際)藥業有限公司) (“Kai Cheung”). At all material times, the defendant (“D”) was and is the registered owner of all the issued shares of Kai Cheung. The plaintiffs (“Ps”) are claiming that at all material times, D was and is holding 30% of the shares on trust for the 1 st plaintiff (“P1”), and another 30% on trust for the 2 nd plaintiff (“P2”). These
Cited by 1 case · Cites 5 cases